Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Arenaviruses other than Lassa virus.

Rémi N Charrel1, Xavier de Lamballerie

  • 1Unité des Virus Emergents, EA 3292, IRD-UR 034, IFR 48, Faculté de Médecine, 27 boulevard Jean Moulin, Marseille 13005, France. virophdm@gulliver.fr

Antiviral Research
|March 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EndoNUclease Heteroduplex cleavage typing a new technique for rapid typing of bacterial isolates in the context of nosocomial outbreaks: proof of concept with <i>Bacillus cereus</i>.

Frontiers in cellular and infection microbiology·2026
Same author

Nine autochthonous cases of Toscana virus infection in France, 2022-2024: a clinical and virological overview.

Journal of travel medicine·2025
Same author

Annual (2024) taxonomic update of RNA-directed RNA polymerase-encoding negative-sense RNA viruses (realm <i>Riboviria</i>: kingdom <i>Orthornavirae</i>: phylum <i>Negarnaviricota</i>).

The Journal of general virology·2025
Same author

External quality assessment for molecular detection of sand fly-borne phleboviruses circulating in the Mediterranean Basin.

Parasites & vectors·2025
Same author

First detection of Jingmen tick virus in Corsica with a new generic RTqPCR system.

Npj viruses·2025
Same author

Low capacity for molecular detection of Alphaviruses other than Chikungunya virus in 23 European laboratories, March 2022.

PloS one·2025
Same journal

The anti-respiratory syncytial virus activity of biochemicals from Pyrola incarnata.

Antiviral research·2026
Same journal

Ginsenoside Rb2-based inactivation enables a Zika vaccine that maintains pregnancy and protects offspring against virus.

Antiviral research·2026
Same journal

ITGA4 drives pathogenesis of flavivirus and inhibition of it protects mice against Japanese encephalitis virus infection.

Antiviral research·2026
Same journal

Corrigendum to "A virus-like particle candidate vaccine based on CRISPR/Cas9 gene editing technology elicits broad-spectrum protection against SARS-CoV-2" [Antivir. Res. 225 (2024) 105854].

Antiviral research·2026
Same journal

Effects of RNA polymerase inhibitors on nucleotidylylation of human norovirus VPg.

Antiviral research·2026
Same journal

Human monoclonal antibodies from donors vaccinated with recombinant vaccinia vaccine targeting A35 and B6 effectively inhibit orthopoxvirus spread and infection.

Antiviral research·2026
See all related articles

Arenaviruses, including Lassa virus, cause hemorrhagic fevers and require high biosafety levels. Research is crucial for developing countermeasures against potential weaponized arenaviruses.

Area of Science:

  • Virology
  • Public Health
  • Biosecurity

Background:

  • The Arenaviridae family comprises 23 viral species, with five known to cause severe viral hemorrhagic fevers (VHFs).
  • These five VHF-causing arenaviruses (Junin, Machupo, Guanarito, Sabia, and Lassa virus) necessitate Biosafety Level 4 (BSL-4) containment.
  • They are classified as Category A pathogens by the CDC due to their high potential for public health impact and mass casualties.

Purpose of the Study:

  • To summarize the current understanding of arenaviruses with hemorrhagic fever potential.
  • To provide insights into the anticipated effects of arenavirus-related public health emergencies.
  • To highlight the critical need for advanced research into diagnostic, preventive, and therapeutic countermeasures against potential arenavirus misuse.

Main Methods:

Related Experiment Videos

  • Literature review and synthesis of existing data on arenaviruses.
  • Analysis of the public health implications and biosecurity risks associated with Category A pathogens.
  • Identification of research gaps in arenavirus countermeasures.

Main Results:

  • Five arenaviruses pose significant hemorrhagic fever risks with high fatality rates.
  • These viruses are recognized as potential bioweapons due to their severity and containment requirements.
  • Current countermeasures are insufficient to address the threat of weaponized arenaviruses.

Conclusions:

  • Urgent development of diagnostic, preventive, and therapeutic tools is essential.
  • Fundamental research is required to create effective countermeasures against naturally occurring and engineered arenaviruses.
  • Enhanced biosecurity and public health preparedness are vital to mitigate arenavirus threats.